High-dose methotrexate in patients with primary central nervous system lymphoma: Does drug exposure really matter?

Markus Joerger, A. D.R. Huitema, G. Illerhaus, A. J.M. Ferreri

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

2 Citaten (Scopus)

Toegang tot document

@article{84567654d8184e1d9a6099c277130ff6,

title = "High-dose methotrexate in patients with primary central nervous system lymphoma: Does drug exposure really matter?",

author = "Markus Joerger and Huitema, {A. D.R.} and G. Illerhaus and Ferreri, {A. J.M.}",

year = "2011",

month = oct,

doi = "10.3109/10428194.2011.580027",

language = "English",

volume = "52",

pages = "1825--1827",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "10",

}

TY - JOUR

T1 - High-dose methotrexate in patients with primary central nervous system lymphoma

T2 - Does drug exposure really matter?

AU - Joerger, Markus

AU - Huitema, A. D.R.

AU - Illerhaus, G.

AU - Ferreri, A. J.M.

PY - 2011/10

Y1 - 2011/10

UR - http://www.scopus.com/inward/record.url?scp=80053210627&partnerID=8YFLogxK

U2 - 10.3109/10428194.2011.580027

DO - 10.3109/10428194.2011.580027

M3 - Comment/debate

C2 - 21657964

AN - SCOPUS:80053210627

SN - 1042-8194

VL - 52

SP - 1825

EP - 1827

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 10

ER -